JANICE SANDIFORD: Open Payments
NPI 1538475421 · LITHONIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 20 payments from 10 companies in 2025. Trend: 2023 $97 · 2024 $214 · 2025 $894
Food & beverage: $722Education: $172
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $216 |
| Janssen Biotech, Inc. | 4 | $188 |
| BeOne Medicines USA, Inc. | 1 | $127 |
| Daiichi Sankyo Inc. | 2 | $104 |
| Eisai Inc. | 1 | $104 |
| ABBVIE INC. | 3 | $59 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| PFIZER INC. | 1 | $24 |
| Becton, Dickinson and Company | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: RYBREVANT, SARCLISA, BRUKINSA, Enhertu, Lenvima, KEYTRUDA, XTANDI, LUPRON DEPOT.
Industry payments across GA — which companies pay providers there.
